The United States represents one of the most advanced and influential regions in the global protein therapeutics landscape, driven by a highly developed biopharmaceutical industry and strong adoption of innovative biologic treatments. The country benefits from robust R&D investment, a favorable regulatory environment through agencies such as the FDA, and the presence of leading...